TP53 and large cell neuroendocrine carcinoma: A rebiopsy of the left supraclavicular fossa lymph node confirmed LCNEC, and repeat NGS did not detect any driver mutations but revealed a TP53 mutation and decreased PD-L1 expression (TPS: 5%; Figure 2F).